Jone Naikabula enjoyed a day to remember on the right wing, crossing the line twice in the second half to extend the lead for ...
GCC-4001 is under clinical development by Artiva Biotherapeutics and currently in Phase I for Rheumatoid Arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback